Literature DB >> 21920074

Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years.

Ntobeko B A Ntusi1, Motasim Badri, Freedom Gumedze, Ambroise Wonkam, Bongani M Mayosi.   

Abstract

BACKGROUND: It is not known whether there are differences in clinical characteristics and outcomes of patients with familial and idiopathic dilated cardiomyopathy (DCM) in an African setting.
PURPOSE: To compare the clinical characteristics and outcomes of familial and idiopathic DCM.
METHODS: We performed a retrospective study of familial and idiopathic DCM at Groote Schuur Hospital, Cape Town, between 1 February 1996 and 31 December 2009. Clinical, electrocardiographic (ECG) and imaging characteristics were compared, in addition to treatment and survival.
RESULTS: Eighty patients with idiopathic DCM and 40 familial cases were studied. ECG T-wave inversion was significantly more frequent in familial DCM (87.5%) than in idiopathic cases (68.8%) (p=0.014), whereas idiopathic patients had a higher prevalence of pathological Q waves (32.5%) than familial cases (12.5%) (p=0.028). Cardiac chambers were significantly more dilated with poorer systolic function in idiopathic than familial cases. A mortality rate of 40% after a median follow-up of 5 years was, however, similar in both groups. The presence of New York Heart Association functional class III and IV symptoms was an independent predictor of mortality (odds ratio (OR) 3.85, 95% confidence interval (CI) 1.30 - 48.47, p<0.001), while heart transplantation was an independent predictor of survival (OR 4.72, 95% CI 1.31 - 72.60, p=0.026) in both groups. Digoxin use without serum monitoring was a significant predictor of mortality in idiopathic DCM (OR 1.62, 95% CI 1.04 - 3.98, p=0.037).
CONCLUSION: Patients with idiopathic DCM have greater cardiac dysfunction than those with familiar disease, but mortality is similarly high in both groups. Digoxin use without drug level monitoring may be associated with increased mortality in idiopathic DCM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920074

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

Review 1.  Exploring unknowns in cardiology.

Authors:  Ottavio Alfieri; Bongani M Mayosi; Seung-Jung Park; Nizal Sarrafzadegan; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2014-09-23       Impact factor: 32.419

Review 2.  Genetics of inherited cardiomyopathies in Africa.

Authors:  Gasnat Shaboodien; Timothy F Spracklen; Stephen Kamuli; Polycarp Ndibangwi; Carla Van Niekerk; Ntobeko A B Ntusi
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 3.  Cardiovascular disease in Africa: epidemiological profile and challenges.

Authors:  Ashley K Keates; Ana O Mocumbi; Mpiko Ntsekhe; Karen Sliwa; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

4.  Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.

Authors:  Maryam Fish; Gasnat Shaboodien; Sarah Kraus; Karen Sliwa; Christine E Seidman; Michael A Burke; Lia Crotti; Peter J Schwartz; Bongani M Mayosi
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

5.  Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.

Authors:  Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2013-04       Impact factor: 1.167

6.  Electrocardiographic predictors of peripartum cardiomyopathy.

Authors:  Kamilu M Karaye; Krister Lindmark; Michael Y Henein
Journal:  Cardiovasc J Afr       Date:  2016 Mar-Apr       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.